Toward a Predict and Prevent Approach in Obstructive Airway Diseases

Area of Science:

• Pulmonary Medicine
• Inflammation Research
• Biomarker Discovery

Background:

• Current asthma and chronic obstructive pulmonary disease (COPD) management relies on diagnosing airflow limitation and symptoms, often leading to delayed treatment.
• This reactive approach allows unchecked airway inflammation, resulting in acute attacks, airway remodeling, and reduced quality of life.
• Existing treatments primarily manage symptoms and exacerbations, failing to address the underlying disease process.

Purpose of the Study:

• To advocate for a paradigm shift from reactive symptom management to a proactive "predict and prevent" model for obstructive airway diseases.
• To highlight the potential of early, targeted anti-inflammatory therapies based on predictive biomarkers.
• To encourage research into identifying and intervening in subclinical airway inflammation to prevent disease progression.

Main Methods:

• Reviewing current diagnostic and treatment paradigms for asthma and COPD.
• Proposing the use of biomarkers such as blood eosinophils and exhaled nitric oxide for early risk assessment.
• Advocating for early intervention with anti-inflammatory therapies in individuals with subclinical airway inflammation.

Main Results:

• The current "damage control" approach is insufficient for modifying the disease course of asthma and COPD.
• Biomarkers like elevated blood eosinophils and exhaled nitric oxide can predict asthma attacks, similar to how blood pressure predicts heart attacks.
• Early intervention in subclinical airway inflammation can potentially prevent the progression to airflow limitation and associated morbidities.

Conclusions:

• A "predict and prevent" strategy is crucial for managing obstructive airway diseases effectively.
• Shifting focus upstream to target the drivers of airway inflammation early is essential for altering disease trajectory.
• Implementing proactive, biomarker-guided anti-inflammatory therapy can lead to improved patient outcomes and potentially clinical remission.